CPAP and Chronic Pain: Is There a Link?
"Exploring the effectiveness of CPAP therapy for veterans with obstructive sleep apnea and chronic pain management, and why adherence matters."
Chronic pain is a widespread and serious problem, especially among veterans and service members. The combination of physical injuries, traumatic brain injuries, and mental health challenges has led to increased reliance on opioid medications to manage pain. However, this approach can have significant drawbacks, including the development of sleep-disordered breathing.
Obstructive sleep apnea (OSA) is a common sleep disorder where breathing repeatedly stops and starts during the night. Continuous positive airway pressure (CPAP) therapy is often prescribed to keep airways open, but its effectiveness in patients with chronic pain who also rely on opioids has been unclear.
A study published in the Journal of Clinical Sleep Medicine investigates how CPAP therapy affects pain intensity and opioid use in veterans with OSA who are already on chronic opioid treatment. Understanding this relationship is essential for improving pain management strategies and overall quality of life for this population.
CPAP Treatment and Practical Limits
CPAP machines treat obstructive sleep apnea (OSA), in which relaxed airways narrow or close during sleep. These breathing interruptions can occur hundreds of times in one night and lead to reduced oxygen. The Cleveland Clinic notes that untreated sleep apnea increases the risk of conditions such as heart disease.
Access and Supply Barriers
A Portland-area reviewer reported that obtaining a new CPAP took a year because of supply and insurance hoops. This account describes a delay in access rather than a milestone in CPAP's development. It illustrates how equipment availability and coverage processes can affect patients' ability to obtain CPAP supplies.
Does CPAP Therapy Reduce Pain and Opioid Use?
The study, led by Philippe Jaoude and colleagues, retrospectively examined data from veterans treated at a VA sleep center. The researchers compared 113 patients with OSA who were using opioid medications for non-malignant pain to a control group of 113 veterans with OSA who were not using opioids. Pain intensity was measured using the Numerical Categorical Scale before CPAP treatment and after 12 months. Opioid intake was assessed using the morphine equivalent daily dose (MEDD), and CPAP adherence was tracked using the device's built-in meter.
- CPAP adherence was significantly lower in the opioid-treated group compared to the control group (37% vs. 55%, p = 0.01).
- Greater pain intensity was the only independent variable associated with CPAP non-adherence at the 12-month follow-up (p = 0.03).
- No significant difference was observed in pain intensity or opioid consumption in CPAP-adherent patients compared to baseline.
Evidence on CPAP and Pain
A systematic review reported that CPAP nonadherence, compared with adherence, was positively associated with pain intensity. However, among patients who adhered to CPAP, adherence did not decrease pain intensity during 12 months of follow-up. These findings suggest that the relationship between CPAP use and pain outcomes remains uncertain rather than establishing CPAP as a pain-reduction treatment.
Limits of Pain Measurement
The reported findings have an important measurement limitation: they were based on a single-item measure of pain. A single-item measure may provide only a narrow assessment of a complex pain experience. This limitation makes the results harder to interpret as a complete account of chronic pain outcomes.
The Importance of CPAP Adherence and Comprehensive Pain Management
The study highlights the importance of CPAP adherence, as veterans on opioids had significantly lower adherence rates than those not on opioids. Pain intensity was identified as the primary factor influencing CPAP adherence, suggesting that managing pain effectively is crucial for improving treatment outcomes.